Abstract

BackgroundThe aim of the study is to test whether use of autologous serum eye‐drops can provide earlier epithelial healing following the application of photorefractive keratectomy.MethodSixty patients (60 eyes) underwent photorefractive keratectomy for myopia. Thirty eyes received autologous serum drops (Study group) while 30 eyes received conventional artificial tears (Control group) after photorefractive keratectomy. An 8 mm epithelial opening was prepared with the application of 18 per cent alcohol for 20 seconds. Photorefractive keratectomy was performed using ESIRIS excimer laser (SCHWIND, Kleinostheim, Germany) with an optic zone of 6.5 mm. Total duration of epithelial healing was monitored as the main outcome measure. The comparisons were done with chi‐square test and independent samples t‐test. Statistical significance was considered at p < 0.05.ResultsPreoperative myopic spherical refraction and ablation depths were similar in the study and control groups. The mean duration for epithelial healing was about one day shorter in the eyes receiving autologous serum compared to the eyes receiving conventional treatment (2.2 ± 0.25 days versus 3 ± 0 days, p = 0.001). All eyes achieved 6/7.5 or better uncorrected visual acuity in six months. In both groups, more than 90 per cent of eyes were within ±0.50 D of emmetropia in 12 months. No significant difference was noted for the incidence of +1 haze.ConclusionUse of autologous serum drops reduces epithelial healing duration following surface ablation for two days.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call